Arteris, Inc. (NASDAQ:AIP – Get Free Report) major shareholder Bayview Legacy, Llc sold 70,000 shares of the firm’s stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $31.20, for a total transaction of $2,184,000.00. Following the completion of the transaction, the insider directly owned 9,049,071 shares in the company, valued at $282,331,015.20. This trade represents a 0.77% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.
Bayview Legacy, Llc also recently made the following trade(s):
- On Wednesday, April 8th, Bayview Legacy, Llc sold 70,000 shares of Arteris stock. The stock was sold at an average price of $19.04, for a total transaction of $1,332,800.00.
- On Tuesday, March 10th, Bayview Legacy, Llc sold 9,000 shares of Arteris stock. The stock was sold at an average price of $14.66, for a total transaction of $131,940.00.
- On Monday, March 9th, Bayview Legacy, Llc sold 41,000 shares of Arteris stock. The stock was sold at an average price of $14.21, for a total transaction of $582,610.00.
Arteris Stock Up 5.0%
Shares of NASDAQ AIP opened at $37.34 on Friday. The company has a 50 day simple moving average of $21.16 and a 200-day simple moving average of $17.47. The company has a market capitalization of $1.72 billion, a P/E ratio of -47.27 and a beta of 1.93. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.73 and a quick ratio of 1.13. Arteris, Inc. has a 1 year low of $6.88 and a 1 year high of $38.47.
Institutional Trading of Arteris
Institutional investors have recently added to or reduced their stakes in the stock. Raymond James Financial Inc. acquired a new stake in Arteris in the 2nd quarter valued at approximately $32,000. BNP Paribas Financial Markets increased its holdings in Arteris by 75.0% in the 3rd quarter. BNP Paribas Financial Markets now owns 6,053 shares of the company’s stock valued at $61,000 after purchasing an additional 2,595 shares during the last quarter. New York State Common Retirement Fund increased its holdings in Arteris by 352.4% in the 4th quarter. New York State Common Retirement Fund now owns 9,500 shares of the company’s stock valued at $147,000 after purchasing an additional 7,400 shares during the last quarter. Mercer Global Advisors Inc. ADV acquired a new stake in Arteris in the 4th quarter valued at approximately $162,000. Finally, Penn Capital Management Company LLC acquired a new stake in Arteris in the 3rd quarter valued at approximately $109,000. Institutional investors and hedge funds own 64.36% of the company’s stock.
Arteris News Roundup
Here are the key news stories impacting Arteris this week:
- Positive Sentiment: Arteris reported a smaller-than-expected Q1 loss of $0.03 per share, ahead of estimates, while revenue of $22.94 million also topped expectations. Article Title
- Positive Sentiment: Management lifted 2026 revenue guidance and guided Q2 sales above prior expectations, which suggests stronger demand and better execution ahead. Article Title
- Positive Sentiment: Rosenblatt Securities sharply raised its price target on Arteris, reinforcing bullish sentiment after the earnings beat and stronger outlook. Article Title
- Positive Sentiment: Analysts highlighted Arteris’ earnings call as evidence of surging growth and a clearer path to profitability. Article Title
- Neutral Sentiment: The company disclosed a CFO retirement, but the market appears focused more on the strong operating results and growth outlook than on the leadership change. Article Title
- Negative Sentiment: A new investor warning flagged Arteris as carrying high risk of significant loss and highlighted shareholder-rights concerns, which could temper enthusiasm at the margins. Article Title
- Negative Sentiment: A major shareholder also sold 70,000 shares, which may add some caution even though the transaction was relatively small versus the holder’s total position. Article Title
Analyst Ratings Changes
A number of analysts have recently issued reports on the stock. Northland Securities set a $38.00 price target on shares of Arteris in a report on Wednesday. Rosenblatt Securities raised their price target on shares of Arteris from $20.00 to $38.00 and gave the stock a “buy” rating in a report on Wednesday. TD Cowen raised their price target on shares of Arteris from $22.00 to $40.00 and gave the stock a “buy” rating in a report on Wednesday. Weiss Ratings downgraded shares of Arteris from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday. Finally, Wall Street Zen downgraded shares of Arteris from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Two equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $37.75.
Read Our Latest Stock Report on Arteris
Arteris Company Profile
Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.
Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.
Featured Stories
- Five stocks we like better than Arteris
- YETI Rallies After Earnings Beat and Raised Outlook
- How the 3 Leading Quantum Firms Stack Up After Q1 Earnings
- Cisco’s Vertical Rally May Still Be in the Early Innings
- Amazon vs. Alibaba: One Is Clearly The Better Value Play right Now
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.
